Meaghan Donahue

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome”.

Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.034

N/A

0.508DataRank · unranked

14 citations

Yan Xiong, Mi‐Ae Jang, Kwang‐Su Park, Meaghan Donahue, Julia Velez +3 more

Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome

Nature Communications(2025)10.1038/s41467-025-61156-8

N/A

0DataRank · unranked

5 citations

Yubao Cheng, Jaechul Lim, Mi‐Ae Jang, Emily Forrest, Yuna Kim +10 more

Deficiency of Shank3 in the nucleus accumbens reveals a loss of social-specific motivation

Communications Biology(2025)10.1038/s42003-025-08942-8

N/A

0DataRank · unranked

2 citations

Meaghan Donahue, Sung Eun Wang, Paola N. Negrón-Moreno, Nicole Xinyen Oo, Sheng-Nan Qiao +3 more